iBio, Inc. (IBIO) Net Cash Provided by (Used in) Financing Activities USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
iBio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • iBio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was $2.47 M, a 117% increase year-over-year.
  • iBio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.3 M.
  • iBio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.13 M, a 108% decline from 2021.
  • iBio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $78.8 M, a 20.9% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $2.47 M +$1.33 M +117% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $1.14 M +$1.23 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 -$88 K -$36.2 M -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2020 $36.1 M +$36.1 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 $0 -$1.14 M -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q3 2018 $1.14 M +$187 K +19.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 $956 K +$997 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q3 2016 -$41 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.